Examination of the Impact of Better Surveillance and Communication of Patient Deterioration on Patient Related Outcomes
2 other identifiers
observational
678
1 country
1
Brief Summary
A hospitals manual method of patient monitoring will be implemented in an automated system and supported by an early patient deterioration detection for timely escalation. The purpose of this study is to assess if clinical outcomes of patients in Acute Care are significantly improved by such a system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2012
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 21, 2012
CompletedFirst Posted
Study publicly available on registry
September 25, 2012
CompletedStudy Start
First participant enrolled
October 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2016
CompletedApril 4, 2016
April 1, 2016
3.3 years
September 21, 2012
April 1, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Improvement of outcome for patients after implementing the IGS
Does the IGS significantly increase positive outcomes for deteriorating patients after referral to the RRT/ACT as measured by the MAELOR score
15 months
Secondary Outcomes (3)
Early detection of patient deterioration
15 months
Daily workload for the ward's personnel
15 months
Level of satisfaction
15 months
Study Arms (2)
RRT calls prior to IGS use
Patients who triggered ACT/RRT calls prior to the installation of the IGS (Intellivue Guardian System)
RRT calls during IGS use
Patients who triggered ACT/RRT calls after the installation of IGS. All patients on the study ward receive the same care in both groups. The only difference is the system used to collect vital signs and to inform the staff about patient deteriorations. In Group 2, the IGS (FDA approved and CE marked) is the vital signs collection and information system.
Eligibility Criteria
The investigators plan to observe a non-probability, convenience sample of patients which will consist primarily of acutely ill hospitalized adult patients (at least 18 years of age). Study participants will be recruited from all eligible patients during the enrollment period who are having vital signs monitoring performed as Standard of Care.
You may qualify if:
- all patients admitted to the study units during the period of data collection
You may not qualify if:
- less than 24h on ward
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ysbyty Gwynedd Hospital
Bangor, Penrhosgarnedd, LL572PW, United Kingdom
Related Publications (1)
Subbe CP, Duller B, Bellomo R. Effect of an automated notification system for deteriorating ward patients on clinical outcomes. Crit Care. 2017 Mar 14;21(1):52. doi: 10.1186/s13054-017-1635-z.
PMID: 28288655DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christian P Subbe, MD
Bangor University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 21, 2012
First Posted
September 25, 2012
Study Start
October 1, 2012
Primary Completion
February 1, 2016
Study Completion
February 1, 2016
Last Updated
April 4, 2016
Record last verified: 2016-04
Data Sharing
- IPD Sharing
- Will not share